530881 — Arunjyoti Bio Ventures Income Statement
0.000.00%
- IN₹1.62bn
- IN₹1.88bn
- IN₹204.68m
- 23
- 23
- 41
- 15
Annual income statement for Arunjyoti Bio Ventures, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2020 March 31st | 2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | Interim Report | ARS |
Standards: | IAS | IAS | IAS | — | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 73.1 | 55.1 | 32.5 | 18.3 | 205 |
Cost of Revenue | |||||
Gross Profit | 12.2 | 7.01 | 3.69 | 3.35 | 119 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 71.8 | 54.2 | 31.7 | 15.6 | 197 |
Operating Profit | 1.31 | 0.938 | 0.77 | 2.66 | 7.93 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1.31 | 0.922 | 0.76 | 2.66 | -13 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.06 | 0.683 | 0.563 | 2.22 | -3.49 |
Net Income Before Extraordinary Items | |||||
Net Income | 1.06 | 0.683 | 0.563 | 2.22 | -3.49 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.06 | 0.683 | 0.563 | 2.22 | -3.49 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.009 | 0.006 | 0.005 | 0.02 | -0.168 |